Outcomes of Radiosurgery for WHO Grade 2 Meningiomas: The Role of Ki-67 Index in Guiding the Tumor Margin Dose
The management of WHO grade 2 meningiomas requires a multimodality approach. This study demonstrates the value of a targeted SRS approach in patients with limited disease and further establishes predictive biomarkers that can guide planning through a personalized approach.
Authors
- Chandranath Sen (ORCID: https://orcid.org/0000-0003-1603-2958)
- Kenneth E. Bernstein (ORCID: https://orcid.org/0000-0001-8097-3272)
- Douglas Kondziolka (ORCID: https://orcid.org/0000-0001-8925-7344)
- John G. Golfinos (ORCID: https://orcid.org/0000-0003-4221-0180)
- Donato R. Pacione (ORCID: https://orcid.org/0000-0002-0731-442X)
- Elad Mashiach (ORCID: https://orcid.org/0000-0002-6135-6268)
- Erik P. Sulman (ORCID: https://orcid.org/0000-0003-4933-9120)
- Nivedha Kannapadi (ORCID: https://orcid.org/0000-0001-7162-9154)
- Matija Snuderl (ORCID: https://orcid.org/0000-0003-0752-0917)
- Joshua S. Silverman (ORCID: https://orcid.org/0000-0002-6962-3826)
- Brandon Santhumayor (ORCID: https://orcid.org/0000-0002-7007-0480)
- Ying Meng (ORCID: https://orcid.org/0000-0003-3180-2404)
- Jason Gurewitz (ORCID: https://orcid.org/0000-0002-8732-968X)
- Bernadine R. Donahue
Institutions
- Maimonides Medical Center (US)
- New York University (US)
Publication Details
- Journal
- Neurosurgery
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1227/neu.0000000000003255
- Citations
- 5
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 1.93